General Information
Drug ID
DR00014
Drug Name
Simeprevir
Synonyms
TMC436
Drug Type
Small molecular drug
Indication Chronic hepatitis C infection [ICD11: 1E51.1] Approved [1]
Therapeutic Class
Antiinfective Agents
Structure
3D MOL 2D MOL
Formula
C38H47N5O7S2
Canonical SMILES
CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC
InChI
InChI=1S/C38H47N5O7S2/c1-21(2)30-20-51-35(40-30)29-18-32(26-13-14-31(49-5)22(3)33(26)39-29)50-24-16-27-28(17-24)36(45)43(4)15-9-7-6-8-10-23-19-38(23,41-34(27)44)37(46)42-52(47,48)25-11-12-25/h8,10,13-14,18,20-21,23-25,27-28H,6-7,9,11-12,15-17,19H2,1-5H3,(H,41,44)(H,42,46)/b10-8-/t23-,24-,27-,28-,38-/m1/s1
InChIKey
JTZZSQYMACOLNN-VDWJNHBNSA-N
CAS Number
CAS 923604-59-5
Pharmaceutical Properties Molecular Weight 749.9 Topological Polar Surface Area 194
Heavy Atom Count 52 Rotatable Bond Count 8
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 10
XLogP
4.8
PubChem CID
24873435
PubChem SID
103036128 , 103587944 , 125086606 , 172919732 , 178103939 , 184811997 , 198993775 , 227100350 , 252166971 , 252216313 , 252237489 , 252480943 , 50128567 , 57162026 , 87551010 , 89449495
ChEBI ID
CHEBI:134743
TTD Drug ID
D00TLP
DT(s) Transporting This Drug OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
References
1 Simeprevir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir. Clin Pharmacokinet. 2016 Feb;55(2):197-208.
3 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.